Biocon Ltd. — Board/Management Information 2021

Apr 28, 2021

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

April 28, 2021

To, The Manager BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001	To, The Manager National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - Biocon

Subject: Change in Key Managerial Personnel of the Company.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Dear Sir/Madam,

With reference to the captioned subject, we would like to inform you that the Board of Directors at its meeting held today, has approved the following:

• Stepping down of Mr. Anupam Jindal as the Chief Financial Officer and Key Managerial Personnel of the Company with immediate effect;

• Appointment of Mr. Indranil Sen, as the Chief Financial Officer and Key Managerial Personnel of the Company, pursuant to the provisions of Section 203 of the Companies Act, 2013 with immediate effect.

In compliance with Regulation 30 of SEBI Listing Regulations, please find enclosed herewith the required disclosures as Annexure A.

The above information will also be available on the website of the company at www.biocon.com.

Kindly take the above information on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

MAYANK Digitally signed by MAYANK VERMA VERMA Date: 2021.04.29 00:09:42 +05'30'

---

Mayank Verma Company Secretary and Compliance Officer

==> picture [132 x 52] intentionally omitted <==

ANNEXURE A

Details under Regulation 30 of the SEBI Listing Regulations read along with SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015

==> picture [487 x 286] intentionally omitted <==

----- Start of picture text -----

S. Remark
Particulars
No.
1. Name Mr. Anupam Jindal Mr. Indranil Sen
Reason for change viz.
2. appointment, resignation, Appointment
Resignation
removal, death or otherwise;
Date of appointment/ cessation
3. (as applicable) & term of April 28, 2021 April 28, 2021
appointment;
Brief profile
4. Attached as Annexure B
NA
(in case of appointment);
Disclosure of relationships
5 between directors (in case of NA NA
appointment of a director).
----- End of picture text -----

ANNEXURE B

Leadership Profile – Mr. Indranil Sen

==> picture [132 x 146] intentionally omitted <==

Mr. Indranil Sen is the Head of Finance at Biocon Limited, an innovations led global pharmaceuticals company. He joined Biocon in 2014 and has, since then, performed various key leadership roles in the finance function.

Indranil has over 17 years of diverse experience in financial planning, treasury, taxation and financial reporting.

He started his career in statutory audit, and has worked in the audit division of B S R & Co. (the Indian arm of KPMG) in Kolkata and S R

Batliboi & Co. (the Indian arm of Ernst & Young) in Bengaluru. Prior to joining Biocon, he was Director, Finance, at Symphony Teleca, a leading US-based multination IT Company. He qualified as a Chartered Accountant from the Institute of Chartered Accountants of India, New Delhi.